Endothelial reconstitution by CD34+ progenitors derived from baboon embryonic stem cells

Qiang Shi, Gerald Schatten, Vida Hodara, Calvin Simerly, John L. Vandeberg

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

In this study, we used a large non-human primate model, the baboon, to establish a step-wise protocol to generate CD34+ endothelial progenitor cells (EPCs) from embryonic stem cells (ESCs) and to demonstrate their reparative effects. Baboon ESCs were sequentially differentiated from embryoid body cultures for 9 days and then were specified into EPCs by culturing them in monolayer for 12 days. The resulting EPCs expressed CD34, CXCR4 and UEA-1, but neither CD31 nor CD117. The EPCs were able to form intact lumen structures when seeded on Matrigel, took up Dil-LDL, and responded to TNF-α. Angioblasts specified in EGM-2 medium and ECGS medium had 6.41 ± 1.16% (n = 3) and 9.32 ± 3.73% CD34+ cells (n = 3). The efficiency of generating CD34+ EPCs did not differ significantly from ECGS to EGM-2 culture media, however, angioblasts specified in ECGS medium expressed a higher percentage of CD34+/CXCR4+ cells (3.49 ± 1.32%, n = 3) than those specified in EGM-2 medium (0.49 ± 0.52%, n = 3). To observe their reparative capacity, we purified CD34+ progenitors after specification by EGM-2 medium; inoculated fluorescently labelled CD34+ EPCs into an arterial segment denuded of endothelium in an ex vivo system. After 14 days of ex vivo culture, the grafted cells had attached and integrated to the denuded surface; in addition, they had matured further and expressed terminally differentiated endothelial markers including CD31 and CD146. In conclusion, we have proved that specified CD34+ EPCs are promising therapeutic agents for repairing damaged vasculature.

Original languageEnglish (US)
Pages (from-to)242-251
Number of pages10
JournalJournal of Cellular and Molecular Medicine
Volume17
Issue number2
DOIs
StatePublished - Feb 2013
Externally publishedYes

Fingerprint

Papio
Embryonic Stem Cells
Embryoid Bodies
Endothelial Progenitor Cells
Primates
Endothelium
Culture Media
Cell Culture Techniques

Keywords

  • Embryonic stem cells
  • Endothelial differentiation
  • Non-human primate model
  • Specification and maturation
  • Stem cell therapy

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Medicine

Cite this

Endothelial reconstitution by CD34+ progenitors derived from baboon embryonic stem cells. / Shi, Qiang; Schatten, Gerald; Hodara, Vida; Simerly, Calvin; Vandeberg, John L.

In: Journal of Cellular and Molecular Medicine, Vol. 17, No. 2, 02.2013, p. 242-251.

Research output: Contribution to journalArticle

Shi, Qiang ; Schatten, Gerald ; Hodara, Vida ; Simerly, Calvin ; Vandeberg, John L. / Endothelial reconstitution by CD34+ progenitors derived from baboon embryonic stem cells. In: Journal of Cellular and Molecular Medicine. 2013 ; Vol. 17, No. 2. pp. 242-251.
@article{4c3385cf55ea4b769fcc3ff6a45b2297,
title = "Endothelial reconstitution by CD34+ progenitors derived from baboon embryonic stem cells",
abstract = "In this study, we used a large non-human primate model, the baboon, to establish a step-wise protocol to generate CD34+ endothelial progenitor cells (EPCs) from embryonic stem cells (ESCs) and to demonstrate their reparative effects. Baboon ESCs were sequentially differentiated from embryoid body cultures for 9 days and then were specified into EPCs by culturing them in monolayer for 12 days. The resulting EPCs expressed CD34, CXCR4 and UEA-1, but neither CD31 nor CD117. The EPCs were able to form intact lumen structures when seeded on Matrigel, took up Dil-LDL, and responded to TNF-α. Angioblasts specified in EGM-2 medium and ECGS medium had 6.41 ± 1.16{\%} (n = 3) and 9.32 ± 3.73{\%} CD34+ cells (n = 3). The efficiency of generating CD34+ EPCs did not differ significantly from ECGS to EGM-2 culture media, however, angioblasts specified in ECGS medium expressed a higher percentage of CD34+/CXCR4+ cells (3.49 ± 1.32{\%}, n = 3) than those specified in EGM-2 medium (0.49 ± 0.52{\%}, n = 3). To observe their reparative capacity, we purified CD34+ progenitors after specification by EGM-2 medium; inoculated fluorescently labelled CD34+ EPCs into an arterial segment denuded of endothelium in an ex vivo system. After 14 days of ex vivo culture, the grafted cells had attached and integrated to the denuded surface; in addition, they had matured further and expressed terminally differentiated endothelial markers including CD31 and CD146. In conclusion, we have proved that specified CD34+ EPCs are promising therapeutic agents for repairing damaged vasculature.",
keywords = "Embryonic stem cells, Endothelial differentiation, Non-human primate model, Specification and maturation, Stem cell therapy",
author = "Qiang Shi and Gerald Schatten and Vida Hodara and Calvin Simerly and Vandeberg, {John L.}",
year = "2013",
month = "2",
doi = "10.1111/jcmm.12002",
language = "English (US)",
volume = "17",
pages = "242--251",
journal = "Journal of Cellular and Molecular Medicine",
issn = "1582-1838",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Endothelial reconstitution by CD34+ progenitors derived from baboon embryonic stem cells

AU - Shi, Qiang

AU - Schatten, Gerald

AU - Hodara, Vida

AU - Simerly, Calvin

AU - Vandeberg, John L.

PY - 2013/2

Y1 - 2013/2

N2 - In this study, we used a large non-human primate model, the baboon, to establish a step-wise protocol to generate CD34+ endothelial progenitor cells (EPCs) from embryonic stem cells (ESCs) and to demonstrate their reparative effects. Baboon ESCs were sequentially differentiated from embryoid body cultures for 9 days and then were specified into EPCs by culturing them in monolayer for 12 days. The resulting EPCs expressed CD34, CXCR4 and UEA-1, but neither CD31 nor CD117. The EPCs were able to form intact lumen structures when seeded on Matrigel, took up Dil-LDL, and responded to TNF-α. Angioblasts specified in EGM-2 medium and ECGS medium had 6.41 ± 1.16% (n = 3) and 9.32 ± 3.73% CD34+ cells (n = 3). The efficiency of generating CD34+ EPCs did not differ significantly from ECGS to EGM-2 culture media, however, angioblasts specified in ECGS medium expressed a higher percentage of CD34+/CXCR4+ cells (3.49 ± 1.32%, n = 3) than those specified in EGM-2 medium (0.49 ± 0.52%, n = 3). To observe their reparative capacity, we purified CD34+ progenitors after specification by EGM-2 medium; inoculated fluorescently labelled CD34+ EPCs into an arterial segment denuded of endothelium in an ex vivo system. After 14 days of ex vivo culture, the grafted cells had attached and integrated to the denuded surface; in addition, they had matured further and expressed terminally differentiated endothelial markers including CD31 and CD146. In conclusion, we have proved that specified CD34+ EPCs are promising therapeutic agents for repairing damaged vasculature.

AB - In this study, we used a large non-human primate model, the baboon, to establish a step-wise protocol to generate CD34+ endothelial progenitor cells (EPCs) from embryonic stem cells (ESCs) and to demonstrate their reparative effects. Baboon ESCs were sequentially differentiated from embryoid body cultures for 9 days and then were specified into EPCs by culturing them in monolayer for 12 days. The resulting EPCs expressed CD34, CXCR4 and UEA-1, but neither CD31 nor CD117. The EPCs were able to form intact lumen structures when seeded on Matrigel, took up Dil-LDL, and responded to TNF-α. Angioblasts specified in EGM-2 medium and ECGS medium had 6.41 ± 1.16% (n = 3) and 9.32 ± 3.73% CD34+ cells (n = 3). The efficiency of generating CD34+ EPCs did not differ significantly from ECGS to EGM-2 culture media, however, angioblasts specified in ECGS medium expressed a higher percentage of CD34+/CXCR4+ cells (3.49 ± 1.32%, n = 3) than those specified in EGM-2 medium (0.49 ± 0.52%, n = 3). To observe their reparative capacity, we purified CD34+ progenitors after specification by EGM-2 medium; inoculated fluorescently labelled CD34+ EPCs into an arterial segment denuded of endothelium in an ex vivo system. After 14 days of ex vivo culture, the grafted cells had attached and integrated to the denuded surface; in addition, they had matured further and expressed terminally differentiated endothelial markers including CD31 and CD146. In conclusion, we have proved that specified CD34+ EPCs are promising therapeutic agents for repairing damaged vasculature.

KW - Embryonic stem cells

KW - Endothelial differentiation

KW - Non-human primate model

KW - Specification and maturation

KW - Stem cell therapy

UR - http://www.scopus.com/inward/record.url?scp=84874379986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874379986&partnerID=8YFLogxK

U2 - 10.1111/jcmm.12002

DO - 10.1111/jcmm.12002

M3 - Article

C2 - 23301772

AN - SCOPUS:84874379986

VL - 17

SP - 242

EP - 251

JO - Journal of Cellular and Molecular Medicine

JF - Journal of Cellular and Molecular Medicine

SN - 1582-1838

IS - 2

ER -